Variant report
Variant | nsv818232 |
---|---|
Chromosome Location | chr4:46589847-46606593 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs34731732 | chr4:46594047-46594048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs140607183 | chr4:46594071-46594072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs145729829 | chr4:46594167-46594168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539637339 | chr4:46594170-46594171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs554761742 | chr4:46594178-46594179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs138195765 | chr4:46594247-46594248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs531614079 | chr4:46594252-46594253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs367722212 | chr4:46594277-46594278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs141179896 | chr4:46594317-46594318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568467369 | chr4:46594359-46594360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs150194993 | chr4:46594361-46594362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs553968340 | chr4:46594385-46594386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs79679039 | chr4:46594396-46594397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540014278 | chr4:46594399-46594400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553440123 | chr4:46603683-46603684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543176497 | chr4:46603721-46603722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571768331 | chr4:46603749-46603750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187326333 | chr4:46603785-46603786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs545991988 | chr4:46603818-46603819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528717173 | chr4:46603868-46603869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73137119 | chr4:46603932-46603933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs564587444 | chr4:46603949-46603950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532114106 | chr4:46603964-46603965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191777548 | chr4:46603966-46603967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs568901531 | chr4:46604063-46604064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147735099 | chr4:46604076-46604077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs574997202 | chr4:46604093-46604094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143999151 | chr4:46604113-46604114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs375892193 | chr4:46604114-46604115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs536413739 | chr4:46604145-46604146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566781448 | chr4:46604157-46604158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs4543080 | chr4:46604215-46604216 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs558869348 | chr4:46604218-46604219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs576679829 | chr4:46604232-46604233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs371710650 | chr4:46604236-46604237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs554168908 | chr4:46604239-46604240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs115181174 | chr4:46604252-46604253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs187478883 | chr4:46604330-46604331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs28405199 | chr4:46604344-46604345 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs193272688 | chr4:46604385-46604386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs575644689 | chr4:46604405-46604406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542819662 | chr4:46604450-46604451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561184173 | chr4:46604476-46604477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs573095386 | chr4:46604541-46604542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540554893 | chr4:46604673-46604674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs368569763 | chr4:46604683-46604684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs371233723 | chr4:46604701-46604702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs565559642 | chr4:46604719-46604720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs374159746 | chr4:46604768-46604769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532030050 | chr4:46604820-46604821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 20164919 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Gastric cancer | 16891809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:46594000-46594400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr4:46603600-46604000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr4:46604000-46605000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr4:46605000-46605400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |